Dr. Stanislav Spiridonov, M.D.
What this data tells you about Dr. Spiridonov
Dr. Stanislav Spiridonov is a student in an organized health care education/training program in Austin, TX, with 14 years in practice. Based on federal Medicare data, Dr. Spiridonov performed 26,689 Medicare services across 2,842 unique beneficiaries.
Between the years covered by Open Payments, Dr. Spiridonov received a total of $546 from 5 pharmaceutical and/or device companies across 13 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Spiridonov is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie | 15,800 | $193 | $497 |
| Contrast dye for imaging (iodine-based) | 6,190 | $0 | $2 |
| MRI contrast dye injection (gadobutrol) | 1,135 | $0 | $1 |
| Chest X-ray, 1 view | 609 | $7 | $138 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 555 | $642 | $2,317 |
| Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | 429 | $751 | $2,722 |
| Gallium ga-68, dotatate, diagnostic, 0.1 millicurie | 223 | $116 | $419 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 168 | $89 | $372 |
| Piflufolastat f-18, diagnostic, 1 millicurie | 109 | $461 | $1,650 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 105 | $37 | $138 |
| Radioactive drug therapy through a vein | 89 | $122 | $629 |
| Nuclear medicine study of bone and/or joint whole body | 83 | $219 | $706 |
| Ct scan of chest with contrast | 80 | $61 | $303 |
| Nuclear medicine study whole body with ct scan | 77 | $360 | $1,544 |
| CT scan of abdomen and pelvis with contrast | 71 | $132 | $733 |
| Blood creatinine level | 69 | $5 | $21 |
| X-ray of abdomen, 1 view | 47 | $7 | $139 |
| Complete ultrasound scan of abdomen | 43 | $54 | $205 |
| Nuclear medicine study of lung ventilation and circulation | 41 | $39 | $694 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 36 | $16 | $418 |
| Knee X-ray, 3 views | 35 | $7 | $114 |
| Ct scan of blood vessels of chest with contrast | 33 | $68 | $1,316 |
| Ct scan of abdomen and pelvis without contrast | 31 | $64 | $1,278 |
| Nuclear medicine study of stomach to assess emptying | 31 | $162 | $505 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 31 | $294 | $1,210 |
| Foot X-ray, 3+ views | 30 | $6 | $103 |
| Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries | 30 | $1,956 | $6,925 |
| Drainage of fluid from abdominal cavity using imaging guidance | 29 | $249 | $850 |
| X-ray of hand, minimum of 3 views | 27 | $7 | $116 |
| Ultrasound scan of head and neck soft tissue | 26 | $88 | $255 |
| CT scan of chest, without contrast | 24 | $56 | $223 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 23 | $27 | $99 |
| Nuclear medicine study of parathyroid with spect and ct scan | 22 | $336 | $1,767 |
| Nuclear medicine study of bone taken at different times | 22 | $262 | $810 |
| X-ray of pelvis, 1-2 views | 21 | $7 | $121 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 21 | $186 | $613 |
| Injection, furosemide, up to 20 mg | 20 | $0 | $7 |
| Chest X-ray, 2 views | 19 | $11 | $75 |
| X-ray of ankle, minimum of 3 views | 19 | $6 | $116 |
| X-ray of lower and sacral spine, 2-3 views | 18 | $9 | $158 |
| Shoulder X-ray, 2+ views | 18 | $11 | $62 |
| Hip X-ray, 2-3 views | 18 | $16 | $70 |
| Limited ultrasound scan of abdomen | 17 | $64 | $233 |
| Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 17 | $462 | $1,213 |
| X-ray of wrist, minimum of 3 views | 16 | $6 | $110 |
| Nuclear medicine study of lymphatic system | 16 | $38 | $833 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 16 | $104 | $520 |
| Nuclear medicine study of liver and bile duct system | 14 | $27 | $526 |
| Ct scan of soft tissue of neck with contrast | 13 | $104 | $552 |
| X-ray of elbow, minimum of 3 views | 13 | $6 | $110 |
| X-ray of forearm, 2 views | 13 | $6 | $105 |
| X-ray of thigh bone, minimum 2 views | 12 | $7 | $147 |
| Nuclear medicine study of brain with metabolic evaluation | 12 | $1,092 | $3,332 |
| Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 12 | $32 | $132 |
| Injection, sincalide, 5 micrograms | 11 | $77 | $464 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Spiridonov is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Spiridonov experienced with lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie?
Does Dr. Spiridonov receive payments from pharmaceutical companies?
How do Dr. Spiridonov's costs compare to other student in an organized health care education/training programs in Austin?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology